Cervical cancer prevention, India set to roll out HPV vaccine in 2023
The Indian-made human papillomavirus (HPV) vaccine, used against cervical cancer in girls aged 9 to 14, will reportedly be included in the country’s national immunization schedule in mid-2023. The announcement of the use of the vaccine, dubbed CERVAVAC, was made by the head of the National Immunization Technical Advisory Group (NTAGI), Narendra Arora. “The vaccine … Read more